Hyperbaric oxygen therapy and the eye

Undersea and Hyperbaric Medicine

Volumn 35, Issue 5, 2008, Pages 333-387

  Butler Jr , F K ^a   Hagan, C ^b   Murphy Lavoie, H ^c  

^a Naval Operational Medicine Institute   (United States)

^b NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AIR EMBOLISM; CARBON MONOXIDE INTOXICATION; DECOMPRESSION SICKNESS; EYE DISEASE; GAS GANGRENE; HUMAN; HYPERBARIC OXYGEN; MUCORMYCOSIS; NECROSIS; NECROTIZING FASCIITIS; PATHOLOGY; RADIATION INJURY; RETINA ARTERY OCCLUSION; RETINA VEIN OCCLUSION; REVIEW; SCLERA; VISUAL DISORDER;

CARBON MONOXIDE POISONING; DECOMPRESSION SICKNESS; EMBOLISM, AIR; EYE DISEASES; FASCIITIS, NECROTIZING; GAS GANGRENE; HUMANS; HYPERBARIC OXYGENATION; MUCORMYCOSIS; NECROSIS; RADIATION INJURIES; RETINAL ARTERY OCCLUSION; RETINAL VEIN OCCLUSION; SCLERA; VISION DISORDERS;

EID: 58149183976     PISSN: 10662936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (374)

1. Regillo D, Chang TS, Johnson MW, et al. Retina and Vitreous: American Academy of Ophthalmology Basic and Clinical Science Course - Section 12. San Francisco: American Academy of Ophthalmology; 2007.
2. Cibis GW, Beaver HA, Johns K, et al. Basic and Clinical Science Course: Fundamentals and Principles of Ophthalmology. American cademy of Opthalmology, San Francisco 2006:38-40.
3. Li HK, Dejean B J, Tang RA. Reversal of visual loss with hyperbaric oxygen treatment in a patient with Susac syndrome. Ophthalmology 1996;103:2091-8.
4. Landers MB, 3rd. Retinal oxygenation via the choroidal circulation. Trans Am Ophthalmol Soc 1978;76:528-56.
5. Patz A. Oxygen inhalation in retinal arterial occlusion; a preliminary report. Am J Ophthalmol 1955;40:789-95.
6. Butler FK, Harris DJ, Reynolds RA. Altitude RetinopathyonMountEverest 1989. Ophthalmology 1992;99:739-46.
7. Resch H, Zawinka C, Weigert G, Schmetterer L, Garhofer G. Inhaled carbon monoxide increases retinal and choroidal blood flow in healthy humans. Invest Ophthalmol Vis Sci 2005;46:4275-80.
8. Ishida S, Usui T, Yamashiro K, et al. VEGF164 is proinflammatory in the diabetic retina. Invest Ophthalmol Vis Sci 2003;44:2155-62.
9. Piantadosi CA. Physiology of hyperbaric hyperoxia. Respir Care Clin N Am 1999;5:7-19.
10. Yu DY, Cringle SJ. Retinal degeneration and local oxygen metabolism. Exp Eye Res 2005;80:745-51.
11. Vucetic M, Jensen PK, Jansen EC. Diameter variations of retinal blood vessels during and after treatment with hyperbaric oxygen. Br J Ophthalmol 2004;88:771-5.
12. Polkinghorne PJ, Bird AC, Cross MR. Retinal vessel constriction under hyperbaric conditions. Lancet 1989;2:1099.
13. Nichols CW, Lambertsen C. Effects of high oxygen pressures on the eye. N Engl J Med 1969;281:25-30.
14. Frayser R, Saltzman HA, Anderson B, Jr.,Hickam JB, Sieker HO. The effect of hyperbaric oxygenation on retinal circulation. Arch Ophthalmol 1967;77:265-9.
15. Anderson B, Saltzman HA. Hyperbaria, hyperoxia, and the retinal and cerebral vessels. Headache 1965;5:73-7.
16. Saltzman HA, Hart L, Sieker HO, Duffy EJ. Retinal vascular response to hyperbaric oxygenation. JAMA 1965;191:114-6.
17. Haddad HM, Leopold IH. Effect of hyperbaric oxygenation on microcirculation: use in therapy of retinal vascular disorders. Invest Ophthalmol 1965;4:1141-51.
18. Jacobson I, Harper AM, McDowall DG. The effects of oxygen under pressure on cerebral blood-flow and cerebral venous oxygen tension. Lancet 1963;25:19.
19. Herbstein K, Murchland JB. Retinal vascular changes after treatment with hyaperbaric oxygen. Med J Aust 1984;140:728-9.
20. James PB. Hyperbaric oxygen and retinal vascular changes. Med J Aust 1985;142:163-4.
21. Jampol LM. Oxygen therapy and intraocular oxygenation. Trans Am Ophthalmol Soc 1987;85:407-37.
22. Dollery CT, Bulpitt CJ, Kohner EM. Oxygen supply to the retina from the retinal and choroidal circulations at normal and increased arterial oxygen tensions. Invest Ophthalmol 1969;8:588-94.
23. Carlisle R, Lanphier EH, Rahn H. Hyperbaric oxygen and persistence of vision in retinal ischemia. J Appl Physiol 1964;19:914-8.
24. Jampol LM, Orlin C, Cohen SB, Zanetti C, Lehman E, Goldberg MF. Hyperbaric and transcorneal delivery of oxygen to the rabbit and monkey anterior segment. Arch Ophthalmol 1988;106:825-9.
25. Gallin-Cohen PF, Podos SM, Yablonski ME. Oxygen lowers intraocular pressure. Invest Ophthalmol Vis Sci 1980; 19:43-8.
26. Moon RE, Camporesi EM. Hyperbaric oxygen therapy: from the nineteenth to the twenty-first century. Respir Care Clin N Am 1999;5:1-5.
27. Cunningham OJ. Oxygen therapy by means of compressed air. Anesth Analg 1927;6:64-6.
28. Feldmeier JJ, ed. Hyperbaric Oxygen 2003: Indications and Results - The Hyperbaric Oxygen Therapy Committee Report. Dunkirk, Undersea and Hyperbaric Medical Society, 2003.
29. Bennett MH, Lehm JP, Mitchell SJ, Wasiak J. Recompression and adjunctive therapy for decompression illness. Cochrane Database Syst Rev 2007:CD005277.
30. Dias MD, Fontes B, Pogetti RS, Birolini D. Hyperbaric oxygen therapy: types of injury and number of sessions. Undersea Hyperb Med 2008;35:53-60.
31. Cianci PB, Slade JB. Delayed treatment of decompression sickness with short, no-break air tables: a review of 140 cases. Aviat Space Environ Med 2006;77:1003.
32. JallaliN, Withey S, Butler PE. Hyperbaric oxygen as adjuvant therapy in the management of necrotizing fasciitis. Am J Surg 2005;189:462-6.
33. Weaver LK, Hopkins RO, Chan KJ, et al. Hyperbaric oxygen for acute carbon monoxide poisoning. N EnglJMed 2002;347:1057-67.
34. McDermott JJ, Dutka AJ, Roller WA, Flynn ET. Effects of an increased PO2 during recompression therapy for the treatment of experimental cerebral arterial gas embolism. Undersea Biomed Res 1992;19:403-13.
35. Bond JG, Moon RE, Morris DL. Initial table treatment of decompression sickness and arterial gas embolism. Aviat Space Environ Med 1990;61:738-43.
36. Brooks GJ, Green RD, Leitch DR. Pulmonary barotrauma in submarine escape trainees and the treatment of cerebral arterial air embolism. Aviat Space Environ Med 1986;57:1201-7.
37. Butler FK, Jr. Diving and hyperbaric ophthalmology. Surv Ophthalmol 1995;39:347-66.
38. Isenberg SJ, Diamant A. Scuba diving after enucleation. Am J Ophthalmol 1985;100:616-7.
39. Butler FK. The Eye in the Wilderness. In: Wilderness Medicine; Auerbach PS, ed: St Louis, Mosby; Fifth Edition 2007.
40. Kokame GT, Ing MR. Intraocular gas and low-altitude air flight. Retina 1994;14:356-8.
41. Mills MD, Devenyi RG, Lam WC, Berger AR, Beijer CD, Lam SR. An assessment of intraocular pressure rise in patients with gas-filled eyes during simulated air flight. Ophthalmology 2001;108:40-4.
42. Lincoff H, Weinberger D, Stergiu P. Air travel with intraocular gas. II. Clinical considerations. Arch Ophthalmol 1989;107:907-10.
43. Polk JD, Rugaber C, Kohn G, Arenstein R, Fallon WF, Jr. Central retinal artery occlusion by proxy: a cause for sudden blindness in an airline passenger. Aviat Space Environ Med 2002;73:385-7.
44. Jackman SV, Thompson JT. Effects of hyperbaric exposure on eyes with ntraocular gas bubbles. Retina 1995;15:160-6.
45. Mekjavic IB, Campbell DG, Jaki P, Dovsak PA. Ocular bubble formation as a method of assessing decompression stress. Undersea Hyperb Med 1998;25:201-10.
46. Steigleman A, Butler F, Chhoeu A, O'Malley T, Bower E, Giebner S. Optic neuropathy following an altitude exposure. Aviat Space Environ Med 2003;74:985-9.
47. Fitzpatrick DT. Visual manifestations of neurologic decompression sickness. Aviat Space Environ Med 1994;65:736-8.
48. Hsu AA, Wong TM, How J, Tan J, Tan KT. Retinal artery occlusion in a diver. Singapore Med J 1992;33:299-301.
49. Butler FK. Decompression sickness presenting as optic neuropathy. Aviat Space Environ Med 1991;62:346-50.
50. Butler FK. Ocular Manifestations of Decompression Sickness. In: Gold T, Weinstein G, eds. The Eye in Systemic Disease. Philadelphia: JB Lippincott, 1990:469-71.
51. Liepmann M. Accommodative and convergence insufficiency after decompression sickness. Arch Ophthalmol 1981;99:453.
52. Davis JC, Sheffield PJ, Schuknecht L, et al. Altitude decompression sickness: hyperbaric therapy results in 145 cases. Aviat Space Environ Med 1977;48:722-30.
53. Summitt JK, Berghage TE. Review of Diving Accident Reports 1968. U.S. Navy Experimental Diving Unit Research Report 11-70, 1970.
54. Rivera JC. Decompression Sickness among Divers: An Analysis of 935 Cases. Mil Med 1964;129:314-34.
55. Van Der Aue O, Dufner G, Behnke A. The treatment of decompression sickness - an analysis of one hundred and thirteen cases. J Industr Hyg Toxicol 1947;29:359-66.
56. U.S. Navy Diving Manual. Washington, DC: Naval Sea Systems Command Publication SS521-AG-PRO-010 (0910-LP-103-8009); Revision 5, 2005:Chapter 3.
57. Butler FK. Central nervous system oxygen toxicity in closed circuit SCUBA divers III. U.S. Navy Experimental Diving Unit Research Report 5-86, 1986.
58. How J, Chan G. Management of delayed cases of decompression sickness-3 case reports. Singapore Med J 1973;14:582-5.
59. Butler FK, Jr., Pinto CV. Progressive ulnar palsy as a late complication of decompression sickness. Ann Emerg Med 1986;15:738-41.
60. Longphre JM, Denoble PJ, Moon RE, Vann RD, Freiberger JJ. First aid normobaric oxygen for the treatment of recreational diving injuries. Undersea Hyperb Med 2007;34:43-9.
61. Rudge FW. Altitude-induced arterial gas embolism: a case report. Aviat Space Environ Med 1992;63:203-5.
62. Wherrett CG, Mehran RJ, Beaulieu MA. Cerebral arterial gas embolism following diagnostic bronchoscopy: delayed treatment with hyperbaric oxygen. Can J Anaesth 2002;49:96-9.
63. Brundin J, Thomasson K. Cardiac gas embolism during carbon dioxide hysteroscopy: risk and management. Eur J Obstet Gynecol Reprod Biol 1989;33:241-5.
64. Grace DM. Air embolism with neurologic complications: a potential hazard of central venous catheters. Can J Surg 1977;20:51-3.
65. Gutman FA, Zegarra H. Ocular complications in cardiac surgery. Surg Clin North Am 1971 ;51:1095-103.
66. Mitchell SJ, Benson M, Vadlamudi L, Miller P. Cerebral arterial gas embolism by helium: an unusual case successfully treated with hyperbaric oxygen and lidocaine. Ann Emerg Med 2000;35:300-3.
67. Pao BS, Hayden SR. Cerebral gas embolism resulting from inhalation of pressurized helium. Ann Emerg Med 1996;28:363-6.
68. Gorman DF. Arterial gas embolism as a consequence of pulmonary barotrauma. In: Desole J, ed: Diving and Hyperbaric Medicine - Proceedings of the IX Congress of the European Undersea Biomedical Society. Barcelona: EUBS, 1978:347-368.
69. Bitterman H, Melamed Y. Delayed hyperbaric treatment of cerebral air embolism. Isr J Med Sci 1993;29:22-6.
70. Bove AA, Clark JM, Simon AJ, Lambertsen CJ. Successful therapy of cerebral air embolism with hyperbaric oxygen at 2.8 ATA. Undersea Biomed Res 1982;9:75-80.
71. Hayreh SS, Zimmerman MB. Central retinal artery occlusion: visual outcome. Am J Ophthalmol 2005;140:376-91.
72. Stone R, Zink H, Klingele T, Burde RM. Visual recovery after central retinal artery occlusion: two cases. Ann Ophthalmol 1977;9:445-50.
73. Duker JS, Brown GC. Recovery following acute obstruction of the retinal and choroidal circulations - a case history. Retina 1988;8:257-60.
74. David NJ, Norton EW, Gass JD, Beauchamp J. Fluorescein angiography in central retinal artery occlusion. Arch Ophthalmol 1967;77:619-29.
75. Hertzog LM, Meyer GW, Carson S, Strauss MB, Hart GB. Central retinal artery occlusion treated with hyperbaric oxygen. J Hyperbaric Medicine 1992;7:33-42.
76. Neubauer AS, Mueller AJ, Schriever S, Gruterich M, Ulbig M, Kampik A. Minimally invasive therapy for clinically complete central retinal artery occlusion-results and meta-analysis of literature. Klin Monatsbl Augenheilkd 2000;217:30-6.
77. Petterson JA, Hill MD, Demchuk AM, al. e. Intraarterial thrombolysis for retinal artery occlusion: the Calgary experience. Can J Neurol Sci 2005;32:507-11.
78. Weber J, Remonda L, Mattle HP, et al. Selective intra-arterial fibrinolysis of acute central retinal artery occlusion. Stroke 1998;29:2076-9.
79. Garcia-Arumi J, Martinez-Castillo V, Boixadera A, Fonollosa A, Corcostegui B. Surgical embolus removal in retinal artery occlusion. Br J Ophthalmol 2006;90:1252-5.
80. Tang WM, Han DP. A study of surgical approaches to retinal vascular occlusions. Arch Ophthalmol 2000;118:138-43.
81. Mangat HS. Retinal artery occlusion. Surv Ophthalmol 1995;40:145-56.
82. Augsburger JJ, Magargal LE. Visual prognosis following treatment of acute central retinal artery obstruction. Br J Ophthalmol 1980;64:913-7.
83. Yu DY, Cringle SJ, Yu PK, Su EN. Intraretinal oxygen distribution and consumption during retinal artery occlusion and graded hyperoxic ventilation in the rat. Invest Ophthalmol Vis Sci 2007;48:2290-6.
84. Phillips D, Diaz C, Atwell G, Chimak J, Ullman S, et al. Care of sudden blindness: a case report of acute central retinal artery occlusion reversed with hyperbaric oxygen therapy. Undersea Hyperb Med 1999;26(Supp):23-4.
85. Hayreh SS, Kolder HE, Weingeist TA. Central retinal artery occlusion and retinal tolerance time. Ophthalmology 1980;87:75-8.
86. Matsuo T. Multiple occlusive retinal arteritis in both eyes of a patient with rheumatoid arthritis. Jpn J Ophthalmol 2001;45:662-4.
87. Weinberger AW, Siekmann UP, Wolf S, Rossaint R, Kirchhof B, Schrage NF. Treatment of acute central retinal artery occlusion (CRAO) by hyperbaric oxygenation therapy (HBO)-pilot study with 21 patients. Klin Monatsbl Augenheilkd 2002;219:728-34.
88. Yotsukura J, Adachi-Usami E. Correlation of electroretinographic changes with visual prognosis in central retinal artery occlusion. Ophthalmologica 1993;207:13-8.
89. Beiran I, Reissman P, Scharf J, Nahum Z, Miller B. Hyperbaric oxygenation combined with nifedipine treatment for recent-onset retinal artery occlusion. Eur J Ophthalmol 1993;3:89-94.
90. Hirayama Y, Matsunaga N, Tashiro J, Amemiya T, Iwasaki M. Bifemelane in the treatment of central retinal artery or vein obstruction. Clin Ther 1990;12:230-5.
91. Henderson LT, Slade JB. Central retinal artery occlusion and hyperbaric oxygen therapy. Undersea Hyperb Med 2004;31:309.
92. Takeuchi M, Morita K, Nakatsuka H, et al. A case of central retinal artery occlusion after anterior posterior fusion of the lumbar spine. Masui 2001;50:899-901.
93. Beiran I, Goldenberg I, Adir Y, Tamir A, Shupak A, Miller B. Early hyperbaric oxygen therapy for retinal artery occlusion. Eur J Ophthalmol 2001;11:345-50.
94. Miyake Y, Horiguchi M, Matsuura M, al. e. Hyperbaric oxygen therapy in 72 eyes with retinal arterial occlusion. In: Bove AA, Bachrach AJ, Greenbaum LJ, eds. Ninth International Symposium on Underwater and Hyperbaric Physiology. Bethesda: Undersea and Hyperbaric Medical Society, 1987:949-953.
95. Mori K, Ohta K, Nagano S, Toshinori M, Yago T, Ichinose Y. A case of ophthalmic artery obstruction following autologous fat injection in the glabellar area. Nippon Ganka Gakkai Zasshi 2007; 111:22-5.
96. Hayreh SS, Podhajsky P. Ocular neovascularization with retinal vascular occlusion. II. Occurrence in central and branch retinal artery occlusion. Arch Ophthalmol 1982;100:1585-96.
97. Murphy-Lavoie H, Harch P, VanMeter K. Effect of hyperbaric oxygen on central retinal artery occlusion. UHMS Scientific Assembly, Australia, 2004.
98. Perkins SA, Magargal LE, Augsburger JJ, Sanborn GE. The idling retina: reversible visual loss in central retinal artery obstruction. Ann Ophthalmol 1987;19:3-6.
99. Anderson B, Jr., Saltzman HA, Heyman A. The Effects of Hyperbaric Oxygenation on Retinal Arterial Occlusion. Arch Ophthalmol 1965;73:315-9.
100. Brummelkamp WH, Hogendyk J, Boerema I. Treatment of anaerobic infections by drenching the tissues with oxygen under high atmospheric pressure. Surgery 1961;49:299-302.
101. Clark LA, Moon RE. Hyperbaric oxygen in the treatment of life-threatening soft-tissue infections. Respir Care Clin N Am 1999;5:203-19.
102. Gopal L, Basti S, Parikh V, Badrinath SS. Gas gangrene panophthalmitis is a rare condition that can occur following penetrating injury with retained intraocular foreign body. Retina 1992;12:74.
103. Wilk CM, Ruprecht KW, Lang GK. Fulminant gas gangrene panophthalmia following perforating scleral injury. Klin Monatsbl Augenheilkd 1989;195:243-7.
104. Kurz GH, Weiss JF. Gas gangrene panophthalmitis. Report of a case. Br J Ophthalmol 1969;53:323-6.
105. Bristow JH, Kassar B, Sevel D. Gas gangrene panophthalmitis treated with hyperbaric oxygen. Br J Ophthalmol 1971;55:139-42.
106. Fielden MP, Martinovic E, Ells AL. Hyperbaric oxygen therapy in the treatment of orbital gas gangrene. J AAPOS 2002;6:252-4.
107. De La Paz MA, Patrinely JR, Marines HM, Appling WD. Adjunctive hyperbaric oxygen in the treatment of bilateral cerebro-rhino-orbital mucormycosis. Am J Ophthalmol 1992;114:208-11.
108. Yohai RA, Bullock JD, Aziz AA, Markert RJ. Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol 1994;39:3-22.
109. Paultauf A. Mycosis mucorina: ein beitrag zur kenntniss dermenschlichen fadenpilzerkrankungen. Virchows Arch 1885;102:543-64.
110. Harris JS. Mucormycosis; report of a case. Pediatrics 1955;16:857-67.
111. Price JC, Stevens DL. Hyperbaric oxygen in the treatment of rhinocerebral mucormycosis. Laryngoscope 1980;90:737-47.
112. Bitterman H. Hyperbaric oxygen for invasive fungal infections. Isr Med Assoc J 2007;9:387-8.
113. Ferguson BJ, Mitchell TG, Moon R, Camporesi EM, Farmer J. Adjunctive hyperbaric oxygen for treatment of rhinocerebral mucormycosis. Rev Infect Dis 1988;10:551-9.
114. Guevara N, Roy D, Dutruc-Rosset C, Santini J, Hofman P, Castillo L. Mucormycosis-early diagnosis and treatment. Rev Laryngol Otol Rhinol (Bord) 2004;125:127-31.
115. Chassaing N, Valton L, Kany M, et al. Rhino-cerebral fungal infection successfully treated with supplementary hyperbaric oxygen therapy. Rev Neurol (Paris) 2003;159:1178-80.
116. Pelton RW, Peterson EA, Patel BC, Davis K. Successful treatment of rhino-orbital mucormycosis without exenteration: the use of multiple treatment modalities. Ophthal Plast Reconstr Surg 2001;17:62-6.
117. Lithander J, Louon A, Worthing E, et al. Orbital entomophthoramycosis in an infant: recovery following surgical debridement, combination antifungal therapy and use of hyperbaric oxygen. Br J Ophthalmol 2001;85:374-5.
118. Bell S, Mahoney L. Mucormycosis: a case study. Crit Care Nurse 2000;20:18-23.
119. Kemper J, Kuijper EJ, Mirck PG, Balm AJ. Recovery from rhinocerebral mucormycosis in a ketoacidotic diabetic patient: a case report. J Laryngol Otol 1993;107:233-5.
120. Melero M, Kaimen Maciel I, Tiraboschi N, Botargues M, Radisic M. Adjunctive treatment with hyperbaric oxygen in a patient with rhino-sinuso-orbital mucormycosis. Medicina (B Aires) 1991;51:53-5.
121. Couch L, Theilen F, Mader JT. Rhinocerebral mucormycosis with cerebral extension successfully treated with adjunctive hyperbaric oxygen therapy. Arch Otolaryngol Head Neck Surg 1988;114:791-4.
122. Schmidt JM, Poublon RM. Rhinocerebral mycosis in immunocompromised patients. A case report and review of the literature. Rhinology 1998;36:90-3.
123. Riseman JA, Zamboni WA, Curtis A, Graham DR, Konrad HR, Ross DS. Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements. Surgery 1990;108:847-50.
124. Knudtson KJ, Gigantelli JW. Necrotizing fasciitis of the eyelids and orbit. Arch Ophthalmol 1998;116:1548-9.
125. Marshall DH, Jordan DR, Gilberg SM, Harvey J, Arthurs BP, Nerad JA. Periocular necrotizing fasciitis: a review of five cases. Ophthalmology 1997;104:1857-62.
126. Kronish JW, McLeish WM. Eyelid necrosis and periorbital necrotizing fasciitis. Report of a case and review of the literature. Ophthalmology 1991;98:92-8.
127. Gozal D, Ziser A, Shupak A, Ariel A, Melamed Y. Necrotizing fasciitis. Arch Surg 1986;121:233-5.
128. Goldberg RA, Li TG. Postoperative infection with group A beta-hemolytic Streptococcus after blepharoplasty. Am J Ophthalmol 2002;134:908-10.
129. Suner IJ, Meldrum ML, Johnson TE, Tse DT. Necrotizing fasciitis after cosmetic blepharoplasty. Am J Ophthalmol 1999;128:367-8.
130. Jordan DR, Mawn L, Marshall DH. Necrotizing fasciitis caused by group A streptococcus infection after laser blepharoplasty. Am J Ophthalmol 1998;125:265-6.
131. Puri P, Innes JR. Necrotizing fasciitis of the orbit: early recognition and treatment a key to success. Eur J Ophthalmol 2001; 11:180-2.
132. Shupak A, Shoshani O, Goldenberg I, Barzilai A, Moskuna R, Bursztein S. Necrotizing fasciitis: an indication for hyperbaric oxygenation therapy? Surgery 1995;118:873-8.
133. Shochat G. Carbon monoxide toxicity. E-medicine website. (Accessed 8 January 2007.
134. Stoller KP. Hyperbaric oxygen and carbon monoxide poisoning: a critical review. Neurol Res 2007;29:146-55.
135. Thorn SR. Hyperbaric-oxygen therapy for acute carbon monoxide poisoning. N Engl J Med 2002;347:1105-6.
136. Piantadosi CA. Carbon monoxide poisoning. N Engl J Med 2002;347:1054-5.
137. Hampson NB. Pulse oximetry in severe carbon monoxide poisoning. Chest 1998;114:1036-41.
138. Kelley JS, Sophocleus GJ. Retinal hemorrhages in subacute carbon monoxide poisoning. Exposures in homes with blocked furnace flues. JAMA 1978;239:1515-7.
139. Ersanli D, Yildiz S, Togrol E, Ay H, Qyrdedi T. Visual loss as a late complication of carbon monoxide poisoning and its successful treatment with hyperbaric oxygen therapy. Swiss Med Wkly 2004;134:650-5.
140. Denniston A. Carbon monoxide poisoning and the eye. J R Soc Med 2001;94:425-6.
141. Simmons IG, Good PA. Carbon monoxide poisoning causes optic neuropathy. Eye 1998;12:809-14.
142. Dempsey LC, O'Donnell JJ, Hoff JT. Carbon monoxide retinopathy. Am J Ophthalmol 1976;82:692-3.
143. Bilchik RC, Muller-Bergh HA, Freshman ME. Ischemic retinopathy due to carbon monoxide poisoning. Arch Ophthalmol 1971;86:142-4.
144. Weaver LK, Valentine KJ, Hopkins RO. Carbon monoxide poisoning: risk factors for cognitive sequelae and the role of hyperbaric oxygen. Am J Respir Crit Care Med 2007;176:491-7.
145. Hampson NB, Little CE. Hyperbaric treatment of patients with carbon monoxide poisoning in the United States. Undersea Hyperb Med 2005;32:21-6.
146. Silver S, Smith C, Worster A. Should hyperbaric oxygen be used for carbon monoxide poisoning? CJEM2006;8:43-6.
147. Bhandare N, Monroe AT, Morris CG, Bhatti MT, Mendenhall WM. Does altered fractionation influence the risk of radiation-induced optic neuropathy? Int J Radiat Oncol Biol Phys 2005;62:1070-7.
148. Finger PT. Anti-VEGF bevacizumab (Avastin) for radiation optic neuropathy. Am J Ophthalmol 2007;143:335-8.
149. Lessell S. Friendly fire: neurogenic visual loss from radiation therapy. J Neuroophthalmol 2004;24:243-50.
150. Jones B, Comins C, Dale RG. Several important omissions in two recent articles concerned with radiation optic neuropathy. Radiother Oncol 2004;70:211-2.
151. Borruat FX, Schatz NJ, Glaser JS, Feun LG, Matos L. Visual recovery from radiation-induced optic neuropathy. The role of hyperbaric oxygen therapy. J Clin Neuroophthalmol 1993;13:98-101.
152. Miller NR. Radiation-induced optic neuropathy: still no treatment. Clin Experiment Ophthalmol 2004;32:233-5.
153. Sallet G, Kestelyn P. Radiation-induced optic neuropathy. Bull Soc Beige Ophtalmol 1992;243:99-107.
154. Borruat FX, Schatz NJ, Glaser JS, Matos L, Feuer W. Radiation optic neuropathy: report of cases, role of hyperbaric oxygen therapy, and literature review. Neuro-Ophthalmology 1996;16:255-66.
155. Guy J, Schatz NJ. Hyperbaric oxygen in the treatment of radiation-induced optic neuropathy. Ophthalmology 1986;93:1083-8.
156. Garrott H, O'Day J. Optic neuropathy secondary to radiotherapy for nasal melanoma. Clin Experiment Ophthalmol 2004;32:330-3.
157. Roden D, Bosley TM, Fowble B, et al. Delayed radiation injury to the retrobulbar optic nerves and chiasm: clinical syndrome and treatment with hyperbaric oxygen and corticosteroids. Ophthalmology 1990;97:346-51.
158. Guy J, Schatz NJ. Effectiveness of hyperbaric oxygen in treating radiation injury to the optic nerves and chiasm. Ophthalmology 1990;97:1246-7.
159. Levy RL, Miller NR. Hyperbaric oxygen therapy for radiation-induced optic neuropathy. Ann Acad Med Singapore 2006;35:151-7.
160. Boschetti M, De Lucchi M, Giusti M, et al. Partial visual recovery from radiation-induced optic neuropathy after hyperbaric oxygen therapy in a patient with Cushing disease. Eur J Endocrinol 2006;154:813-8.
161. Munoz S, Amiga J, Martin N. Radiation optic neuropathy treated with hyperbaric oxygen and steroids: stabilization after late treatment. Neuro-Ophthalmology 2004;28:259-64.
162. Gall N, Leiba H, Handzel R, Pe'er J. Severe radiation retinopathy and optic neuropathy after brachytherapy for choroidal melanoma treated by hyperbaric oxygen. Eye 2007;21:1010-2.
163. Girkin CA, Comey CH, Lunsford LD, Goodman ML, Kline LB. Radiation optic neuropathy after stereotactic radiosurgery. Ophthalmology 1997;104:1634-43.
164. Ryu S, Kolozsvary A, Jenrow KA, Brown SL, Kim JH. Mitigation of radiation-induced optic neuropathy in rats by ACE inhibitor ramipril: importance of ramipril dose and treatment time. J Neurooncol 2007;82:119-24.
165. Danesh-Meyer HV, Savino PJ, Sergott RC. Visual loss despite anticoagulation in radiation-induced optic neuropathy. Clin Experiment Ophthalmol 2004;32:333-5.
166. Finger PT, Chin K. Anti-vascular endothelial growth factor bevacizumab (Avastin) for radiation retinopathy. Arch Ophthalmol 2007;125:751-6.
167. Feldmeier J J, Hampson NB. A systematic review of the literature reporting the application of hyperbaric oxygen prevention and treatment of delayed radiation injuries: an evidence based approach. Undersea Hyperb Med 2002;29:4-30.
168. Gonnering RS, Kindwall EP, Goldmann RW. Adjunct hyperbaric oxygen therapy in periorbital reconstruction. Arch Ophthalmol 1986;104:439-43.
169. Sebban A, Hirst LW. Pterygium recurrence rate at the Princess Alexandra Hospital. Aust N Z J Ophthalmol 1991;19:203-6.
170. Bayer A, Mutlu FM, Sobaci G. Hyperbaric oxygen therapy for mitomycin C-induced scleral necrosis. Ophthalmic Surg Lasers 2002;33:58-61.
171. Green MO, Brannen AL. Hyperbaric oxygen therapy for beta-radiation- induced scleral necrosis. Ophthalmology 1995;102:1038-41.
172. Hayreh SS, Zimmerman MB. Nonarteritic anterior ischemic optic neuropathy: natural history of visual outcome. Ophthalmology 2008;115:298-305.
173. Matthews MK. Nonarteritic anterior ischemic optic neuropathy. Curr Opin Ophthalmol 2005;16:341-5.
174. O1verJM, SpaltonDJ, McCartney AC. Microvascular study of the retrolaminar optic nerve in man: the possible significance in anterior ischaemic optic neuropathy. Eye 1990;4:7-24.
175. Desai N, Patel MR, Prisant LM, Thomas DA. Nonarteritic anterior ischemic optic neuropathy. J Clin Hypertens 2005;7:130-3.
176. Hayreh SS, Zimmerman MB. Incipient nonarteritic anterior ischemic optic neuropathy. Ophthalmology 2007;114:1763-72.
177. Arnold AC, Hepler RS, Lieber M, Alexander JM. Hyperbaric oxygen therapy for nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1996;122:535-41.
178. Bojic L, Ivanisevic M, Gosovic G. Hyperbaric oxygen therapy in two patients with non-arteritic anterior optic neuropathy who did not respond to prednisone. Undersea Hyperb Med 2002;29:86-92.
179. Bojic L, Kovacevic H, Andric D, Karaman-Kraljevic K, Cagalj S. The effects of hyperbaric oxygen on visual functions in ischaemic optic neuropathy. Arh Hig Rada Toksikol 1994;45:19-24.
180. Bojic L, Cerovski B, Bucan K, et al. Hyperbaric oxygen for the treatment of nonarteritic anterior ischemic optic neuropathy. Acta Med Croatica 1995;49:133-6.
181. Beiran I, Rimon I, Weiss G, Pikkel J, Miller B. Hyperbaric oxygenation therapy for ischemic optic neuropathy. Eur J Ophthalmol 1995;5:285-6.
182. Arnold AC, Levin LA. Treatment of ischemic optic neuropathy. Semin Ophthalmol 2002;17:39-46.
183. Keynan Y, Yanir Y, Shupak A. Hyperbaric therapy for bilateral visual loss during hemodialysis. Clin Exp Nephrol 2006;10:82-4.
184. Wells M, Foroozan R. Transient visual loss may anticipate occipital infarction from hemodialysis. Am J Kidney Dis 2004;43:29-33.
185. Cuxart M, Matas M, Picazo M, Sans R, Juvanet J, Osuna T. Acute bilateral visual loss in a hemodialysed patient. Nefrologia 2005;25:703-5.
186. Buono LM, Foroozan R, Savino PJ, Danesh-Meyer HV, Stanescu D. Posterior ischemic optic neuropathy after hemodialysis. Ophthalmology 2003;110:1216-8.
187. Arora N, Lambrou FH Jr, Stewart MW, Vidrine-Parks L, Sandroni S. Sudden blindness associated with central nervous symptoms in a hemodialysis patient. Nephron 1991;59:490-2.
188. Newman NJ, Scherer R, Langenberg P, et al. The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol 2002;134:317-28.
189. Hayreh SS, Zimmerman B. Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies. Ophthalmologica 2003;217:239-59.
190. Hayreh SS, Podhajsky PA, Zimmerman B. Ocular manifestations of giant cell arteritis. Am J Ophthalmol 1998;125:509-20.
191. Boyd SR, Zachary I, Chakravarthy U, et al. Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion. Arch Ophthalmol 2002;120:1644-50.
192. Glacet-Bernard A, Coscas G, Chabanel A, Zourdani A, Lelong F, Samama MM. Prognostic factors for retinal vein occlusion: a prospective study of 175 cases. Ophthalmology 1996;103:551-60.
193. Fong AC, Schatz H. Central retinal vein occlusion in young adults. Surv Ophthalmol 1993;37:393-417.
194. Mohamed Q, Mcintosh RL, Saw SM, Wong TY. Interventions for central retinal vein occlusion: an evidence-based systematic review. Ophthalmology 2007;114:507-19.
195. Hayreh SS. Management of central retinal vein occlusion. Ophthalmologica 2003;217:167-88.
196. Miyamoto H, Ogura Y, Honda Y. Hyperbaric oxygen treatment for macular edema after retinal vein occlusion-fluorescein angiographic findings and visual prognosis. Nippon Ganka Gakkai Zasshi 1995;99:220-5.
197. Bhatt UK. Radial optic neurotomy in retinal vein occlusion. Am J Ophthalmol 2004;137:970-1.
198. The Central Retinal Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 1997;115:486-91.
199. Hasselbach HC, Ruefer F, Feltgen N, et al. Treatment of central retinal vein occlusion by radial optic neurotomy in 107 cases. Graefes Arch Clin Exp Ophthalmol 2007;245:1145-56.
200. Weizer JS, Stinnett SS, Fekrat S. Radial optic neurotomy as treatment for central retinal vein occlusion. Am J Ophthalmol 2003;136:814-9.
201. Madhusudhana KC, Newsom RS. Central retinal vein occlusion: the therapeutic options. Can J Ophthalmol 2007;42:193-5.
202. Feltgen N, Junker B, Agostini H, Hansen LL. Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study. Ophthalmology 2007;114:716-23.
203. Shahid H, Hossain P, Amoaku WM. The management of retinal vein occlusion: is interventional ophthalmology the way forward? Br J Ophthalmol 2006;90:627-39.
204. The Central Retinal vein Occlusion Study Group. A randomized clinical trial of early panretinal photocoagulation for ischemic retinal vein occlusion. Ophthalmology 1995; 102 1434-44.
205. Lee YH, Lee JY, Kim YS, Kim DH, Kim J. Successful anticoagulation for bilateral central retinal vein occlusions accompanied by cerebral venous thrombosis. Arch Neurol 2006;63:1648-51.
206. Spandau UH, Ihloff AK, Jonas JB. Intravitreal bevacizumab treatment of macular oedema due to central retinal vein occlusion. Acta Ophthalmol Scand 2006;84:555-6.
207. Wright JK, Franklin B, Zant E. Clinical case report: treatment of a central retinal vein occlusion with hyperbaric oxygen. Undersea Hyperb Med 2007;34:315-9.
208. Johnson GP. Cases from the aerospace medicine residents' teaching file: Case #38. A navigator with nonischemic central retinal vein occlusion progressing to ischemic central retinal vein occlusion. Aviat Space Environ Med 1990;61:962-5.
209. Miyamoto H, Ogura Y, Wakano Y, Honda Y. The long term results of hyperbaric oxygen treatment for macular edema with retinal vein occlusion. Nippon Ganka Gakkai Zasshi 1993;97:1065-9.
210. Gismondi A, Colonna S, Micalella F, Metrangolo C. Hyperbaric oxygen therapy in thrombotic occlusion of the central retinal vein. Minerva Med 1981;72:1413-5.
211. Greiner KH, Lang GE. Risk-adapted management of central vein occlusions. Ophthalmologe 1999;96:736-40.
212. Lang GE, Kuba GB. High-altitude retinopathy. Am J Ophthalmol 1997;123:418-20.
213. Yuzurihara D, Ijima H. Visual outcome in central retinal and branch retinal artery occlusion. Jpn J Ophthalmol 2004;48:490-2.
214. Ros MA, Magargal LE, Uram M. Branch retinal artery obstruction: a review of 201 eyes. Ann Ophthalmol 1989;21:103-7.
215. Yamamoto K, Tsujikawa A, Hangai M, Fujihara M, Iwawaki T, Kurimoto Y. Neovascular glaucoma after branch retinal artery occlusion. Jpn J Ophthalmol 2005;49:388-90.
216. Mason JO 3rd, Nixon PA, Albert MA Jr. Transluminal nd:YAG laser embolysis for branch retinal artery occlusion. Retina 2007;27:573-7.
217. Aisenbrey S, Krott R, Heller R, Krauss D, Rossler G, Heimann K. Hyperbaric oxygen therapy in retinal artery occlusion. Ophthalmologe 2000;97:461-7.
218. Imai E, Kunikata H, Udono T, Nakagawa Y, Abe T, Tamai M. Branch retinal artery occlusion: a complication of iron-deficiency anemia in a young adult with a rectal carcinoid. Tohoku J Exp Med 2004;203:141-4.
219. Branch Retinal Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 1984;98:271-82.
220. Klein R, Klein BE, Moss SE, Meuer SM. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 2000;98:133-41.
221. Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountain Eye Study. Arch Ophthalmol 1996;114:1243-7.
222. Kumar B, Yu DY, Morgan WH, Barry CJ, Constable IJ, McAllister IL. The distribution of angioarchitectural changes within the vicinity of the arteriovenous crossing in branch retinal vein occlusion. Ophthalmology 1998;105:424-7.
223. Weinberg D, Dodwell DG, Fern SA. Anatomy of arteriovenous crossings in branch retinal vein occlusion. Am J Ophthalmol 1990;109:298-302.
224. Frangieh GT, Green WR, Barraquer-Somers E, Finkelstein D. Histopathologic study of nine branch retinal vein occlusions. Arch Ophthalmol 1982;100:1132-40.
225. Clemett RS, Kohner EM, Hamilton AM. The visual prognosis in retinal branch vein occlusion. Trans Ophthalmol Soc UK 1973;93:523-35.
226. The Branch Retinal Vein Occlusion Study Group. Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion: a randomized clinical trial. Arch Ophthalmol 1986;104:34-41.
227. Gutman FA, Zegarra H. Macular edema secondary to occlusion of retinal veins. Surv Ophthalmol 1984;26:462-70.
228. Greer DV, Constable I J, Cooper RL. Macular oedema and retinal branch vein occlusion. Aust J Ophthalmol 1980;8:207-9.
229. Gutman FA, Zegarra H. The natural course of temporal retinal branch vein occlusion. Trans Am Acad Ophthalmol Otolaryngol 1974;78:178-92.
230. Michels RG, Gass JD. The natural course of retinal branch vein obstruction. Trans Am Acad Ophthalmol Otolaryngol 1974;78:166-77.
231. Mcintosh RL, Mohamed Q Saw SM, Wong TY. Interventions for branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology 2007;114:835-54.
232. Clemett RS. Preretinal membranes. Trans Ophthalmol Soc N Z 1984;36:25-30.
233. Hayreh SS. Classification of central retinal vein occlusion. Ophthalmology 1983;90:458-74.
234. Gass JDM, Norton EDW. Cystoid macular edema and papilledema following cataract exgtraction: a fluorescein fundoscopic and angiographic study. Arch Ophthalmol 1966;76:221-4.
235. Gass JD, Anderson DR, Davis EB. A clinical, fluorescein angiographic, and electron microscopic correlation of cystoid macular edema. Am J Ophthalmol 1985;100:82-6.
236. Coscas G, Gaudric A. Natural course of nonaphakic cystoid macular edema. Surv Ophthalmol 1984;28 (Suppl):471-84.
237. Quinlan PM, Elman MJ, Bhatt AK, Mardesich P, Enger C. The natural course of central retinal vein occlusion. Am J Ophthalmol 1990; 110:118-23.
238. Dick JSB, Jampol LM, Haller JA. Macular edema. In: Ryan SJ, ed: Retina. St. Louis: Mosby, 2001:973-985.
239. Vinores S A, Youssri Al, Luna JD, et al. Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol Histopathol 1997;12:99-109.
240. Schaal KB, Hoh AE, Scheuerle A, Schutt F, Dithmar S. Bevacizumab for the treatment of macular edema secondary to retinal vein occlusion. Ophthalmologe 2007;104:285-9.
241. Rabena MD, Pieramici DJ, Castellarin AA, Nasir MA, Avery RL. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina 2007;27:419-25.
242. Iturralde D, Spaide RF, Meyerle CB, et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina 2006;26:279-84.
243. Tamura H, Miyamoto K, Kiryu J, et al. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina. Invest Ophthalmol Vis Sci 2005;46:1440-4.
244. Rosenfeld PJ, Fung AE, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 2005;36:336-9.
245. Antonetti DA, Wolpert EB, DeMaio L, Harhaj NS, Scaduto RC. Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin. J Neurochem 2002;80:667-77.
246. Gardner TW, Antonetti DA, Barber AJ, Lieth E, Tarbell JA. The molecular structure and function of the inner blood-retinal barrier. Penn State Retina Research Group. Doc Ophthalmol 1999;97:229-37.
247. Nauck M, Karakiulakis G, Perruchoud AP, Papakonstantinou E, Roth M. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur J Pharmacol 1998;341:309-15.
248. Nauck M, Roth M, Tamm M, Eickelberg O, et al. Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is down-regulated by corticosteroids. Am J Resp Cell Mol Biol 1998;16:398-406.
249. Cox SN, Hay E, Bird AC. Treatment of chronic macular edema with acetazolamide. Arch Ophthalmol 1988;106:1190-5.
250. Marmor MF, Maack T. Enhancement of retinal adhesion and subretinal fluid resorption by acetazolamide. Invest Ophthalmol Vis Sci 1982;23:121-4.
251. Park CH, Jaffe GJ, Fekrat S. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol 2003; 136:419-25.
252. Jonas JB, Akkoyun I, Kreissig I, Degenring RF. Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comparative, non-randomized study. Br J Ophthalmol 2005;89:321-6.
253. Ozkiris A, Evereklioglu C, Erkilic K, Ilhan O. The efficacy of intravitreal triamcinolone acetonide on macular edema in branch retinal vein occlusion. Eur J Ophthalmol 2005; 15:96-101.
254. Avitabile T, Longo A, Reibaldi A. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema. Am J Ophthalmol 2005;140:695-702.
255. Williamson TH, O'Donnell A. Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion. Am J Ophthalmol 2005;139:860-6.
256. Chen SD, Lochhead J, Patel CK, Frith P. Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion. Br J Ophthalmol 2004;88:154-5.
257. BashshurZF, Ma'lufRN, Allam S, Jurdi FA, Haddad RS, Noureddin BN. Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion. Arch Ophthalmol 2004; 122:1137-40.
258. Ip MS. Intravitreal injection of triamcinolone: an emerging treatment for diabetic macular edema. Diabetes Care 2004;27:1794-7.
259. Greenberg PB, Martidis A, Rogers AH, Duker JS, Reichel E. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 2002;86:247-8.
260. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2002;240:782-3.
261. Osterloh MD, Charles S. Surgical decompression of branch retinal vein occlusions. Arch Ophthalmol 1988;106:1469-71.
262. Kumagai K, Furukawa M, Ogino N, Larson E, Uemura A. Long-term visual outcomes after vitrectomy for macular edema with foveal hemorrhage in branch retinal vein occlusion. Retina 2007;27:584-8.
263. Mason J 3rd, Feist R, White M Jr, Swanner J, McGwin G Jr, Emond T. Sheathotomy to decompress branch retinal vein occlusion: a matched control study. Ophthalmology 2004;111:540-5.
264. Mester U, Dillinger P. Vitrectomy with arteriovenous decompression and internal limiting membrane dissection in branch retinal vein occlusion. Retina 2002;22:740-6.
265. Shah GK, Sharma S, Fineman MS, Federman J, Brown MM, Brown GC. Arteriovenous adventitial sheathotomy for the treatment of macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 2000;129:104-6.
266. Opremack EM, Bruce RA. Surgical decompression of branch retinal vein occlusion via arteriovenous crossing sheathotomy: a prospective review of 15 cases. Retina 1999;19:1-5.
267. Cahill MT, Kaiser PK, Sears JE, Fekrat S. The effect of arteriovenous sheathotomy on cystoid macular oedema secondary to branch retinal vein occlusion. Br J Ophthalmol 2003;87:1329-32.
268. LeRouic JF, Beggani RA, Rumen F, et al. Adventitial sheathotomy for decompression of recent onset branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2001;239:747-51.
269. The Central Retinal Vein Occlusion Study Group. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. Ophthalmology 1994; 102:1425-33.
270. Molnar I, Poitry S, Tsacopoulos M, Gilodi N, Leuenberger PM. Effect of laser photocoagulation on oxygenation of the retina in miniature pigs. Invest Ophthalmol Vis Sci 1985;26:1410-4.
271. Blankenship GW, Okun E. Retinal tributary vein occlusion. History and management by photocoagulation. Arch Ophthalmol 1973;89:363-8.
272. Campbell CJ, Wise GN. Photocoagulation therapy of branch retinal vein obstructions. Am J Ophthalmol 1973;75:28-31.
273. Krill AE, Archer D, Newell FW. Photocoagulation in complications secondary to branch retinal vein occlusion. Arch Ophthalmol 1971;85:48-60.
274. Shilling JS, Jones C A. Retinal branch vein occlusion: a study of argon laser photocoagulation in the treatment of macular oedema. Br J Ophthalmol 1984;68:196-8.
275. Wetzig PC. The treatment of acute branch vein occlusion by photocoagulation. Am J Ophthalmol 1979;87:65-73.
276. Tranos PG, Wickremasinghe SS, Stangos NT, Topouzis F, Tsinopoulos I, Pavesio CE. Macular edema. Surv Ophthalmol 2004;49:470-90.
277. Jansen EC, Nielsen NV. Promising visual improvement of cystoid macular oedema by hyperbaric oxygen therapy. Acta Ophthalmol Scand 2004;82:485-6.
278. Krott R, Heller R, Aisenbrey S, Bartz-Schmidt KU. Adjunctive hyperbaric oxygenation in macular edema of vascular origin. Undersea Hyperb Med 2000;27:195-204.
279. Kiryu J, Ogura Y. Hyperbaric oxygen treatment for macular edema in retinal vein occlusion: relation to severity of retinal leakage. Ophthalmologica 1996;210:168-70.
280. Miyake Y, Awaya S, Takahashi H, Tomita N, Hirano K. Hyperbaric oxygen and acetazolamide improve visual acuity in patients with cystoid macular edema by different mechanisms. Arch Ophthalmol 1993;111:1605-6.
281. Mandai M, Ogura Y, Honda Y Effects of hyperbaric oxygen treatment on macular edema. Folia Ophthalmol Jpn 1990;41:578-83.
282. Ogura Y, Takahashi M, Ueno S, Honda Y. Hyperbaric oxygen treatment for chronic cystoid macular edema after branch retinal vein occlusion. Am J Ophthalmol 1987;104:301-2.
283. Roy M, Bartow W, Ambrus J, Fauci A, Collier B, Titus J. Retinal leakage in retinal vein occlusion: reduction afterhyperbaricoxygen.Ophthalmologica 1989;198:78-83.
284. Xu YN, Huang JG. Hyperbaric oxygen treatment for cystoid macular edema secondary to retinal vein occlusion. Zhonghua Yan Ke Za Zhi 1991;27:216-8.
285. Ishida K, Suzuki A, Ogino N. Oxygenation under hyperbaric pressure for cystoid macular edema. Jpn J Clin Ophthalmol 1989;43:1171-4.
286. Pfoff DS, Thom SR. Preliminary report on the effect of hyperbaric oxygen on cystoid macular edema. J Cataract Refract Surg 1987; 13:136-40.
287. Coma MC, Sobrin L, Onal S, Christen W, Foster CS. Intravitreal bevacizumab for treatment of uveitic macular edema. Ophthalmology 2007; 114:1574-9.
288. Okinami S, Nihira M, Iwaki M, Sunakawa M, Arai I. Hyperbaric oxygen therapy for cystoid macular edema in uveitis. Jpn J Clin Ophthalmol 1992;46:199-201.
289. Suttorp-Schulten MS, Riemslag FC, Rothova A, van der Kley AJ. Long-term effect of repeated hyperbaric oxygen therapy on visual acuity in inflammatory cystoid macular oedema. Br J Ophthalmol 1997;81:329.
290. Jarvis RM, Neufeld MV, Westfall CT. Brown recluse spider bite to the eyelid. Ophthalmology 2000;107:1492-6.
291. Boland ME, Roper SM, Henry J A. Complications of quinine poisoning. Lancet 1985;1:384-5.
292. Dyson EH, Proudfoot AT, Prescott LF, Heyworth R. Death and blindness due to overdose of quinine. Br Med J 1985;291:31-3.
293. Wolff RS, Wirtschafter D, Adkinson C. Ocular quinine toxicity treated with hyperbaric oxygen. Undersea Hyperb Med 1997;24:131-4.
294. Bacon P, Spalton DJ, Smith SE. Blindness from quinine toxicity. Br J Ophthalmol 1988;72:219-24.
295. Sharma AG, Kazim NA, Eliott D, Houghton O, Abrams G W. Purtscher's retinopathy that occurred 6 months before acute pancreatitis. Am J Ophthalmol 2006;141:205-7.
296. Sanders RJ, Brown GC, Brown A, Gerner EW. Purtscher's retinopathy preceding acute pancreatitis. Ann Ophthalmol 1992;24:19-21.
297. Agrawal A, McKibbin M. Purtscher's retinopathy: epidemiology, clinical features and outcome. Br J Ophthalmol 2007;91:1456-9.
298. Carrera CR, Pierre LM, Medina FM, Pierre-Filho Pde T. Purtscher-like retinopathy associated with acute pancreatitis. Sao Paulo Med J. 2005;123:289-91.
299. Lin YC, Yang CM, Lin CL. Hyperbaric oxygen treatment in Purtscher's retinopathy induced by chest injury. J Chin Med Assoc 2006;69:444-8.
300. Foster-Moore R. Radiation retinopathy. Transactions of the Ophthalmological Societies of the UK 1935;55:3-26.
301. Quinn AG, Clemett RS. Retinopathy after low-dose retinal irradiation. Aust N Z J Ophthalmol 1993;21:193-7.
302. Saunders RA, Bluestein EC, Wilson ME, Berland JE. Anterior segment ischemia after strabismus surgery. Surv Ophthalmol 1994;38:456-66.
303. de Smet MD, Carruthers J, Lepawsky M. Anterior segment ischemia treated with hyperbaric oxygen. Can J Ophthalmol 1987;22:381-3.
304. Murdock TJ, Kushner BJ. Anterior segment ischemia after surgery on two vertical rectus muscles augmented with lateral fixation sutures. J AAPOS 2001;5:323-4.
305. Pfister RR. The intraocular changes of anteriorsegment necrosis. Eye 1991;5:214-21.
306. Freilich DB, Seelenfreund MH. Hyperbaric oxygen, retinal detachment, and sickle cell anemia. Arch Ophthalmol 1973;90:90-3.
307. Freilich DB, Seelenfreund MH. The use of hyperbaric oxygen in the treatment of retinal detachment in patients with sickle cell disease. Isr JMedSci 1972;8:1458-61.
308. Freilich DB, Seelenfreund MH. Further studies in the use of hyperbaric oxygen in retinal detachment with sickle cell anemia. Mod Probl Ophthalmol 1975;15:313-7.
309. Freilich DB, Seelenfreund MH. Long-term follow-up of scleral buckling procedures with sickle cell disease and retinal detachment treated with the use of hyperbaric oxygen. Mod Probl Ophthalmol 1977;18:368-72.
310. Shauly Y, Nachum Z, Gdal-On M, Melamed Y, Miller B. Adjunctive hyperbaric oxygen therapy for actinomycotic lacrimal canaliculars. Graefes Arch Clin Exp Ophthalmol 1993;231:429-31.
311. Newman WD, Frank HJ. Pyoderma gangrenosum of the orbit. Eye 1993;7:89-94.
312. Chong R, Ayer CJ, Francis IC, Coroneo MT, Wolfers DL. Adjunctive hyperbaric oxygen in pseudomonas keratitis. Br J Ophthalmol 2007;91:560-1.
313. Averous K, Erginay A, Timsit J, Haouchine B, Gaudric A, Massin P. Resolution of diabetic macular oedema following high altitude exercise. Acta Ophthalmol Scand 2006;84:830-1.
314. Ogura Y, Kiryu J, Takahashi K, Honda Y. Visual improvement in diabetic macular edema by hyperbaric oxygen treatment. Nippon Ganka Gakkai Zasshi 1988;92:1456-60.
315. Fischer BH, Marks M, Reich T. Hyperbaric oxygen treatment of multiple sclerosis: a randomized, placebo-controlled, double-blind study. N Engl J Med 1983;308:181-6.
316. Bennett M, Heard R. Hyperbaric oxygen therapy for multiple sclerosis. Cochrane Database Syst Rev 2004:CD003057.
317. Bennett M, Heard R. Treatment of multiple sclerosis with hyperbaric oxygen therapy. Undersea Hyperb Med 2001;28:117-22.
318. Neiman J, Nilsson BY, Barr PO, Perrins DJ. Hyperbaric oxygen in chronic progressive multiple sclerosis: visual evoked potentials and clinical effects. J Neurol Neurosurg Psychiatry 1985;48:497-500.
319. Perrins DJ, James PB. Hyperbaric oxygen therapy and multiple sclerosis. Undersea Hyperb Med 2002;29:236-8.
320. Baumgartner WA. Etiology, pathogenesis, and experimental treatment of retinitis pigmentosa. Med Hypotheses 2000;54:814-24.
321. Vingolo EM, Pelaia P, Forte R, Rocco M, Giusti C, Rispoli E. Does hyperbaric oxygen (HBO) delivery rescue retinal photoreceptors in retinitis pigmentosa? Doc Ophthalmol 1999;97:33-9.
322. Skogstad M, Bast-Pettersen R, Tynes T, Bjomsen D, Aaserud O. Treatment with hyperbaric oxygen. Illustrated by the treatment of a patient with retinitis pigmentosa. Tidsskr Nor Laegeforen 1994;114:2480-3.
323. Kuroki AM, Kitaoka T, Taniguchi H, Amemiya T. Hyperbaric oxygen therapy reduces visual field defect after macular hole surgery. Ophthalmic Surg Lasers 2002;33:200-6.
324. Mervin K, Valter K, Maslim J, Lewis G, Fisher S, Stone J. Limiting photoreceptor death and deconstruction during experimental retinal detachment: the value of oxygen supplementation. Am J Ophthalmol 1999;128:155-64.
325. Lewis G, Mervin K, Valter K, et al. Limiting the proliferation and reactivity of retinal Muller cells during experimental retinal detachment: the value of oxygen supplementation. Am J Ophthalmol 1999;128:165-72.
326. Ersanli D, Karadayi K, Toyran S, et al. The efficacy of hyperbaric oxygen for the treatment of experimental uveitis induced in rabbits. Ocul Immunol Inflamm 2005;13:383-8.
327. Hirst LW, Summers PM, Griffiths D, Bancroft J, Lillicrap GR. Controlled trial of hyperbaric oxygen treatment for alkali corneal burn in the rabbit. Clin Experiment Ophthalmol 2004;32:67-70.
328. Ng JD, Nunery WR, Martin RT, Ng PA, Bonnin JM, Elkins AD. Effects of hyperbaric oxygen therapy on hydroxyapatite orbital implant vascularization in rabbits. Ophthal Plast Reconstr Surg 2001; 17:254-63.
329. DeBacker CM, Dutton JJ, Proia AD, Halperin EC, Wagle TN, Hoick DE. The influence of hyperbaric oxygen therapy and irradiation on hydroxyapatite ocular implant exposure and fibrovascular ingrowth in New Zealand white rabbits. Ophthal Plast Reconstr Surg 1999;15:412-9.
330. Bojic L, Kovacevic H, Andric D, Romanovic D, Petri NM. Hyperbaric oxygen dose of choice in the treatment of glaucoma. Arh Hig Rada Toksikol 1993;44:239-47.
331. Bojic L, Racic G, Gosovic S, Kovacevic H. The effect of hyperbaric oxygen breathing on the visual field in glaucoma. Acta Ophthalmol (Copenh) 1993;71:315-9.
332. Henkind P. Hyperbaric oxygen and corneal neovascularisation. Lancet 1964;2:836-8.
333. Kern M, Sommerauer P, Wocheslander E, Schuhmann G, Kohek P, Stolze A. Use of hyperbaric oxygen therapy in patients with tobacco-alcohol amblyopia. Fortschr Ophthalmol 1986;83:312-4.
334. Recupero SM, Cruciani F, Picardo V, Sposato PA, Tamanti N, Abdolrahimzadeh S. Hyperbaric oxygen therapy in the treatment of secondary keratoendotheliosis. Ann Ophthalmol 1992;24:448-52.
335. Wallyn CR, Jampol LM, Goldberg MF, Zanetti CL. The use of hyperbaric oxygen therapy in the treatment of sickle cell hyphema. Invest Ophthalmol Vis Sci 1985;26:1155-8.
336. Ehlers JP, Shah CP, eds. The Wills Eye Manual. Baltimore: Lippincott Williams and Wilkins, 2008:442-3.
337. Oguz H, Sobaci G. The use of hyperbaric oxygen therapy in ophthalmology. Surv Ophthalmol 2008;53:112-20.
338. Donald KW. Oxygen and the Diver. Worshester: The Spa, Ltd, 1992:104.
339. Hendricks PL, Hall DA, Hunter WL Jr, Haley PJ. Extension of pulmonary O2 tolerance in man at 2 ATA by intermittent O2 exposure. J Appl Physiol 1977;42:593-9.
340. Shupak A, Abramovich A, Adir Y, et al. Effects on pulmonary function of daily exposure to dry or humidified hyperbaric oxygen. Respir Physiol 1997;108:241-6.
341. Thorsen E, Aanderud L, Aasen TB. Effects of a standard hyperbaric oxygen treatment protocol on pulmonary function. Eur Respir J 1998; 12:1442-5.
342. Butler FK, Smith DJ. United States Navy Diving Techniques and Equipment. In: Bove and Davis Diving Medicine. Bove AA, ed. Philadelphia: WB Saunders, Fourth Edition, 2004:372-87.
343. Butler FK, Thalmann ED. Central nervous system oxygen toxicity in closed circuit scuba divers II. Undersea Biomed Res 1986;13:193-223.
344. Butler FK, Thalmann ED. Central nervous system oxygen toxicity in closed circuit SCUBA divers. In: Bachrach AJ, Matzen MM, eds. Underwater Physiology VIII: Proceedings of the Eighth Symposium in Underwater Physiology. Bethesda: Undersea Medical Society; 1984:15-30
345. Pontani BA, Alexander K, Williams RL. 10,000 dives: a comprehensive review of 14 years of experience. Undersea Hyperb Med 2007;34:273.
346. Witucki P, Grover I, Ducknick J, Neuman T. Incidence of oxygen seizures in HBO chamber attendants. Undersea Hyperb Med 2007;34:250.
347. Nichols CW, Lambertsen CJ, Clark JM. Transient unilateral loss of vision associated with oxygen at high pressure. Arch Ophthalmol 1969;81:548-52.
348. Clark JM Thom S. Oxygen under pressure. In: Brubakk AO NT, ed. Bennett and Eliott's Physiology and Medicine of Diving. London: WB Saunders, 2003:358-418.
349. Kinney JS. Human Underwater Vision: Physiology and Physics. Bethesda: Undersea and Hyperbaric Society,1985.T58.
350. Behnke AR, Forbes HS, Motley EP. Circulatory and visual effects of oxygen at 3 atmospheres pressure. Am J Physiol 1935;114:436-42.
351. Lambertsen CJ, Clark JM, Gelfand R. Definition of tolerance in continuous hyperoxia in man: an abstract report of Predictive Studies V. In: Proceedings of the Ninth International Symposium on Underwater and Hyperbaric Physiology. Bove AA, bachrach AJ, Greenbaum LJ, eds. Bethesda: Undersea and Hyperbaric Medical Society, 1987:717-735.
352. Miller EF. Effect of breathing 100 per cent oxygen upon visual field and visual acuity. J Aviat Med 1958;29:598-602.
353. Bridges WZ. Electroretinographic manifestations of hyperbaric oxygen. Arch Ophthalmol 1966;75:812- 7.
354. Noell WK. Effect of high and low oxygen tension on the visual system. In: Schaeffer KE, ed. Environmental effects on consciousness. New York: MacMillan, 1962:3-18.
355. Beehler CC, Newton NL, Culver JF, Tredici T. Ocular Hyperoxia. Aerosp Med 1963;34:1017-20.
356. Ubels JL, Hoffert JR. Ocular oxygen toxicity: the effect of hyperbaric oxygen on retinal Na+-K+ ATPase. Exp Eye Res 1981;32:77-84.
357. Patz A. The effect of oxygen on immature retinal vessels. Invest Ophthalmol 1965;4:988-99.
358. Terry TL. Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens: a preliminary report. Am J Ophthalmol 1942;25:203.
359. Beehler CC. Oxygen and the eye. Aeromed Rev 1964;3:1-21.
360. Fledelius HC, Jansen EC, Thorn J. Refractive change during hyperbaric oxygen therapy. A clinical trial including ultrasound oculometry. Acta Ophthalmol Scand 2002;80:188-90.
361. Thorn SR, Clark JM. The toxicity of oxygen, carbon monoxide, and carbon dioxide. In: Bove AA, ed. Bove and davis Diving Medicine. Philadelphia; WB Saunders,1997:131-145.
362. Ross ME, Yolton DP, Yolton RL, Hyde KD. Myopia associated with hyperbaric oxygen therapy. Optom VisSci 1996;73:487-94.
363. Anderson B, Shelton D. Axial length in hyperoxic myopia. 1987:607-11.
364. Palmquist BM, Philipson B, Barr PO. Nuclear cataract and myopia during hyperbaric oxygen therapy. Br J Ophthalmol 1984;68:113-7.
365. Anderson B, Jr., Farmer JC, Jr. Hyperoxic myopia. Trans Am Ophthalmol Soc 1978;76:116-24.
366. Lyne AJ. Ocular effects of hyperbaric oxygen. Trans Ophthalmol Soc UK 1978;98:66-8.
367. Butler FK, White E, Twa M. Hyperoxic myopia in a closed-circuit mixed-gas scuba diver. Undersea Hyperb Med 1999;26:41-5.
368. Evanger K, Haugen OH, Aanderud L, Thorsen E, Pierscionek BK. Hypermetropia-succeeded myopia after hyperbaric oxygen therapy. Optom Vis Sci 2006;83:195-8.
369. Fledelius HC, Jansen E. Hypermetropic refractive change after hyperbaric oxygen therapy. Acta Ophthalmol Scand 2004;82:313-4.
370. Gesell LB, Trott A. De novo cataract development following a standard course of hyperbaric oxygen therapy. Undersea Hyperb Med 2007';34:389-92.
371. McCartney PJ, McCartney PW. Vitreous haemorrhage after hyberbaric oxygen therapy. Eye 1994;8:705-6.
372. Nichols CW, Yanoff M, Hall DA, Lambertsen CJ. Histologic alterations produced in the eye by oxygen at high pressure. Arch Ophthalmol 1972;87:417-21.
373. Winkle RK, Mader TH, Parmley VC, White LJ, Poise KA. The etiology of refractive changes at high altitude after radial keratotomy: hypoxia vs hypobaria. Ophthalmology 1998;105:282.
374. Evanger K, Haugen OH, Irgens A, Aanderud L, Thorsen E. Ocular refractive changes in patients receiving hyperbaric oxygen administered by oronasal mask or hood. Acta Ophthalmol Scand 2004;82:449-53.